Decreased expression of the NFκB transcription factor and the NFκB activator RIPK2 was unexpected, as UVR activates the NFκB pathway in many melanoma cells, and these cells constitutively express both NFκB and an alternative activator NIK [20]. Here, RIPK2 is linked to melanoma.